mAbxience | CDMO



Independent CDMO platform with 40+ years of experience within Insud Pharma Group, providing clients with end-to-end solutions.
mAbxience CDMO business offers a complete service from small R&D and clinical batches to full commercial production:

  • Process & analytical development infrastructure from process development to optimization and scale up.
  • Robust processes following cGMP manufacturing guidelines.
  • Constantly expanding global capacities and capabilities with flexibility provided from 3L to 4,000L single-use bioreactors.
  • Internal and external Technology Transfer expertise.
  • Extensive knowledge of both fed batch and perfusion technology.
  • Cell line development capabilities.
  • Examples of product offerings include monoclonal antibodies, monoclonal antibodies, bispecific antibodies, chimeric or fusion proteins, adenovirus or baculovirus vaccines, mRNA, etc.

Contact mAbxience CDMO

CDMO (Compañía para Desarrollo y Fabricación por Contrato de medicamentos)